CymitQuimica logo

CAS 811803-05-1

:

N-[4-(1-Cianociclopentil)fenil]-2-[(4-piridinilmetil)amino]-3-piridinocarboxamida

Descrição:
N-[4-(1-Cianociclopentil)fenil]-2-[(4-piridinilmetil)amino]-3-piridinocarboxamida, com número CAS 811803-05-1, é um composto orgânico sintético caracterizado por sua complexa estrutura molecular, que inclui múltiplos anéis aromáticos e grupos funcionais. Este composto apresenta uma espinha dorsal de piridina carboxamida, conhecida por sua potencial atividade biológica, particularmente em química medicinal. A presença de um grupo cianociclopentílico e um substituinte amino piridinilmetílico sugere que pode interagir com vários alvos biológicos, possivelmente influenciando vias relacionadas ao câncer ou outras doenças. Sua solubilidade, estabilidade e reatividade dependeriam das condições específicas, como pH e solvente, devido à presença de grupos funcionais polares. Além disso, o peso molecular do composto, o ponto de fusão e as propriedades espectrais (como NMR e IR) forneceriam mais informações sobre suas características e potenciais aplicações no desenvolvimento de medicamentos ou como ferramenta de pesquisa em bioquímica. No geral, este composto representa uma classe de moléculas que poderia ser de interesse na pesquisa farmacêutica.
Fórmula:C24H23N5O
InChI:InChI=1S/C24H23N5O/c25-17-24(11-1-2-12-24)19-5-7-20(8-6-19)29-23(30)21-4-3-13-27-22(21)28-16-18-9-14-26-15-10-18/h3-10,13-15H,1-2,11-12,16H2,(H,27,28)(H,29,30)
Chave InChI:InChIKey=WPEWQEMJFLWMLV-UHFFFAOYSA-N
SMILES:C(#N)C1(CCCC1)C2=CC=C(NC(=O)C3=C(NCC=4C=CN=CC4)N=CC=C3)C=C2
Sinónimos:
  • 3-Pyridinecarboxamide, N-[4-(1-cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-
  • Apatinib
  • Apatinib (YN968D1)
  • Apatinib mesylate
  • Aptinib
  • N-[4-(1-Cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide
  • N-[4-(1-cyanocyclopentyl)phenyl]-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide
  • Rivoceranib
  • Yn 968D1
  • N-[4-(1-Cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]pyridine-3-carboxamide
Ordenar por

Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 produtos.
  • Apatinib

    CAS:
    Fórmula:C24H23N5O
    Peso molecular:397.48

    Ref: 4Z-A-367001

    5mg
    A consultar
    10mg
    444,00€
    25mg
    635,00€
    50mg
    825,00€
    100mg
    A consultar
  • N-(4-(1-Cyanocyclopentyl)phenyl)-2-((pyridin-4-ylmethyl)amino)nicotinamide

    CAS:
    N-(4-(1-Cyanocyclopentyl)phenyl)-2-((pyridin-4-ylmethyl)amino)nicotinamide
    Pureza:99%
    Peso molecular:397.48g/mol

    Ref: 54-OR1066769

    25mg
    194,00€
    50mg
    315,00€
    100mg
    533,00€
    250mg
    885,00€
  • Apatinib

    Produto Controlado
    CAS:
    <p>Applications Apatinib is an orally available, small molecule multitargeted tyrosine kinase inhibitor. Apatinib selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2). Apatinib functions by inhibiting VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue. Recent studies have shown that Apatinib enhances the efficacy of conventional chemotherapeutical drugs in side population (SP) cells and ABCB1-overexpressing leukemia cells.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Mi, Y. et al.: Cancer Res., 70, 7981 (2010); Tong, X.Z. et al.: Biochem. Pharmacol., 83, 586 (2012); Ding, J, et al.: J. Chrom B Anal. Technol. Biomed. Life Sci., 895, 108 (2012);<br></p>
    Fórmula:C24H23N5O·CH4O3S
    Cor e Forma:Neat
    Peso molecular:493.58

    Ref: TR-A726150

    25mg
    276,00€
    100mg
    1.145,00€
    250mg
    1.777,00€
  • Apatinib-d8

    Produto Controlado
    CAS:
    <p>Applications Apatinib-d8 is an intermediate used in the synthesis of Apatinib-d8 Hydrochloride (A726152), which is a labelled Apatinib (A726150). Apatinib is an orally available, small molecule multitargeted tyrosine kinase inhibitor. Apatinib selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2). Apatinib functions by inhibiting VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue. Recent studies have shown that Apatinib enhances the efficacy of conventional chemotherapeutical drugs in side population (SP) cells and ABCB1-overexpressing leukemia cells.<br>References Mi, Y. et al.: Cancer Res., 70, 7981 (2010); Tong, X.Z. et al.: Biochem. Pharmacol., 83, 586 (2012); Ding, J, et al.: J. Chrom B Anal. Technol. Biomed. Life Sci., 895, 108 (2012);<br></p>
    Fórmula:C24H15D8N5O
    Cor e Forma:Neat
    Peso molecular:405.53

    Ref: TR-A726153

    5mg
    313,00€
    50mg
    2.057,00€
  • Apatinib

    CAS:
    <p>Apatinib, also known as rivoceranib, is an inhibitor of the vascular endothelial growth factor receptor 2 (VEGFR2) tyrosine kinase. Apatinib targets VEGFR2 with its action and has proven to have strong anti-tumor effects in human cancers. In studies in mice, apatinib acted as an Inhibitor of VEGFR2 and played an antiangiogenic effect. Apatinib has been suggested for the treatment of ischemia-induced proliferative retinopathy and neovascular age-related macular degeneration.</p>
    Fórmula:C24H23N5O
    Pureza:Min. 95%
    Cor e Forma:Powder
    Peso molecular:397.47 g/mol

    Ref: 3D-BA175030

    10mg
    208,00€
    25mg
    387,00€
    50mg
    514,00€
    100mg
    730,00€